CO3-610 as a Biomarker for Liver Fibrosis in Rats
Author Information
Author(s): Toni Segovia-Silvestre, Vedrana Reichenbach, Guillermo Fernández-Varo, Efstathios Vassiliadis, Natasha Barascuk, Manuel Morales-Ruiz, Morten A Karsdal, Wladimiro Jiménez
Primary Institution: Nordic Bioscience A/S, Herlev, Denmark
Hypothesis
Can CO3-610 be used as a surrogate biomarker of liver fibrosis and portal hypertension in rats?
Conclusion
CO3-610 is a reliable indicator of liver remodeling and portal hypertension in experimental fibrosis.
Supporting Evidence
- Serum CO3-610 levels were significantly higher in rats with severe fibrosis and cirrhosis compared to controls.
- A strong correlation was found between serum CO3-610 levels and hepatic collagen content.
- CO3-610 levels also correlated significantly with portal hypertension.
Takeaway
This study found that a specific protein called CO3-610 can help doctors see how bad liver damage is in rats, which might help in treating people with liver problems.
Methodology
The study involved measuring serum CO3-610 levels in Wistar rats with induced liver fibrosis and correlating these levels with liver collagen content and portal pressure.
Limitations
The study was conducted in rats, and results may not directly translate to humans.
Participant Demographics
68 male Wistar rats were used in the study.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website